SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-24-000057
Filing Date
2024-07-23
Accepted
2024-07-22 20:18:07
Documents
19
Period of Report
2024-07-22

Document Format Files

Seq Description Document Type Size
1 6-K a2024-07x23clbppatientenro.htm 6-K 25198
2 EX-99.1 exhibit991.htm EX-99.1 9730
3 EX-99.2 exhibit992.htm EX-99.2 4224
4 EX-99.3 exhibit993.htm EX-99.3 15654
5 EX-99.4 exhibit994.htm EX-99.4 11582
6 exhibit991001.jpg GRAPHIC 286428
7 exhibit991002.jpg GRAPHIC 290977
8 exhibit992001.jpg GRAPHIC 125655
9 exhibit992002.jpg GRAPHIC 128760
10 exhibit993001.jpg GRAPHIC 76679
11 exhibit993002.jpg GRAPHIC 59785
12 exhibit993003.jpg GRAPHIC 57156
13 exhibit993004.jpg GRAPHIC 121849
14 exhibit993005.jpg GRAPHIC 95947
15 exhibit993006.jpg GRAPHIC 53991
16 exhibit994001.jpg GRAPHIC 76298
17 exhibit994002.jpg GRAPHIC 53480
18 exhibit994003.jpg GRAPHIC 72646
19 exhibit994004.jpg GRAPHIC 116716
  Complete submission text file 0001345099-24-000057.txt   2294276
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 241132702
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)